323 related articles for article (PubMed ID: 29742191)
1. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
[TBL] [Abstract][Full Text] [Related]
2. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
3. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
[TBL] [Abstract][Full Text] [Related]
4. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
[TBL] [Abstract][Full Text] [Related]
5. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
6. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
[TBL] [Abstract][Full Text] [Related]
7. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
[TBL] [Abstract][Full Text] [Related]
8. PRAME immunohistochemistry of spitzoid neoplasms.
Koh SS; Lau SK; Scapa JV; Cassarino DS
J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.
Gerami P; Yao Z; Polsky D; Jansen B; Busam K; Ho J; Martini M; Ferris LK
J Am Acad Dermatol; 2017 Jan; 76(1):114-120.e2. PubMed ID: 27707590
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.
Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Patereli A; Stratigos A; Katsambas A
J Am Acad Dermatol; 2007 May; 56(5):815-24. PubMed ID: 17437889
[TBL] [Abstract][Full Text] [Related]
11. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
[TBL] [Abstract][Full Text] [Related]
12. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
[TBL] [Abstract][Full Text] [Related]
13. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
[TBL] [Abstract][Full Text] [Related]
15. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas.
Erickson LA; Letts GA; Shah SM; Shackelton JB; Duncan LM
Mod Pathol; 2009 Jul; 22(7):969-76. PubMed ID: 19396153
[TBL] [Abstract][Full Text] [Related]
16. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
17. [Spitz nevus and Reed nevus: simulating melanoma in adults].
Paredes B; Hardmeier T
Pathologe; 1998 Nov; 19(6):403-11. PubMed ID: 9885003
[TBL] [Abstract][Full Text] [Related]
18. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
Bahmad HF; Oh KS; Alexis J
J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
[TBL] [Abstract][Full Text] [Related]
19. Management of Spitz nevi: a survey of dermatologists in the United States.
Gelbard SN; Tripp JM; Marghoob AA; Kopf AW; Koenig KL; Kim JY; Bart RS
J Am Acad Dermatol; 2002 Aug; 47(2):224-30. PubMed ID: 12140468
[TBL] [Abstract][Full Text] [Related]
20. Spitz nevi display allelic deletions.
Bogdan I; Burg G; Böni R
Arch Dermatol; 2001 Nov; 137(11):1417-20. PubMed ID: 11708943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]